Cat. No.: DIA-0243091
Product Information | |
---|---|
Synonyms | (Pro3) Gastric Inhibitory Peptide, human TFA |
Formula | C226H338N60O64S.xC2HF3O2 |
Molecular Weight | 4951.53 (free base) |
Target | Insulin Receptor |
Product Description | (Pro3) GIP, human TFA is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human TFA has high binding affinity for human GIPR with Ki/ Kd value of 0.90 nM. (Pro3) GIP, human TFA human can be used for the research of obesity-related diabetes. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.79% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Solubility Overview | Soluble in water |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.